Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Periocular Triamcinolone vs. Intravitreal Triamcinolone vs. Intravitreal Dexamethasone Implant for the Treatment of Uveitic Macular Edema: The PeriOcular vs. INTravitreal corticosteroids for uveitic macular edema (POINT) TrialOphthalmology (Rochester, Minn.), 2019-02, Vol.126 (2), p.283 [Peer Reviewed Journal]Copyright © 2018 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved. ;EISSN: 1549-4713 ;DOI: 10.1016/j.ophtha.2018.08.021 ;PMID: 30269924Digital Resources/Online E-Resources |
|
2 |
Material Type: Article
|
DEXAMETHASONE IMPLANT FOR DIABETIC MACULAR EDEMA IN NAIVE COMPARED WITH REFRACTORY EYES: The International Retina Group Real-Life 24-Month Multicenter Study. The IRGREL-DEX StudyRetina (Philadelphia, Pa.), 2019-01, Vol.39 (1), p.44 [Peer Reviewed Journal]EISSN: 1539-2864 ;DOI: 10.1097/IAE.0000000000002196 ;PMID: 29697589Digital Resources/Online E-Resources |
|
3 |
Material Type: Article
|
Early and Long-term Responses to Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema: Analysis of Protocol I DataAmerican journal of ophthalmology, 2016-12, Vol.172, p.72-79 [Peer Reviewed Journal]2016 The Authors ;Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Dec 01, 2016 ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2016.09.012 ;PMID: 27644589 ;CODEN: AJOPAAFull text available |
|
4 |
Material Type: Article
|
Perihematomal Edema and Functional Outcomes in Intracerebral Hemorrhage: Influence of Hematoma Volume and LocationStroke (1970), 2015-11, Vol.46 (11), p.3088-3092 [Peer Reviewed Journal]2015 American Heart Association, Inc. ;ISSN: 0039-2499 ;EISSN: 1524-4628 ;DOI: 10.1161/STROKEAHA.115.010054 ;PMID: 26396030Full text available |
|
5 |
Material Type: Article
|
Safety and Efficacy of Ranibizumab in Diabetic Macular Edema (RESOLVE Study): A 12-month, randomized, controlled, double-masked, multicenter phase II studyDiabetes care, 2010-11, Vol.33 (11), p.2399-2405 [Peer Reviewed Journal]2015 INIST-CNRS ;COPYRIGHT 2010 American Diabetes Association ;Copyright American Diabetes Association Nov 2010 ;2010 by the American Diabetes Association. ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc10-0493 ;PMID: 20980427 ;CODEN: DICAD2Full text available |
|
6 |
Material Type: Article
|
Intravitreal Aflibercept for Diabetic Macular Edema: 148-Week Results from the VISTA and VIVID StudiesOphthalmology (Rochester, Minn.), 2016-11, Vol.123 (11), p.2376 [Peer Reviewed Journal]Copyright © 2016 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved. ;EISSN: 1549-4713 ;DOI: 10.1016/j.ophtha.2016.07.032 ;PMID: 27651226Digital Resources/Online E-Resources |
|
7 |
Material Type: Article
|
AFLIBERCEPT FOR PERSISTENT DIABETIC MACULAR EDEMA: Forty-Eight-Week OutcomesRetina (Philadelphia, Pa.), 2019-01, Vol.39 (1), p.61 [Peer Reviewed Journal]EISSN: 1539-2864 ;DOI: 10.1097/IAE.0000000000002253 ;PMID: 30015767Digital Resources/Online E-Resources |
|
8 |
Material Type: Article
|
Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III studyOphthalmology (Rochester, Minn.), 2010-06, Vol.117 (6), p.1102 [Peer Reviewed Journal]Copyright 2010 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved. ;EISSN: 1549-4713 ;DOI: 10.1016/j.ophtha.2010.02.021 ;PMID: 20398941Digital Resources/Online E-Resources |
|
9 |
Material Type: Article
|
Intravitreal Aflibercept Injection for Macular Edema Resulting from Central Retinal Vein Occlusion: One-Year Results of the Phase 3 GALILEO StudyOphthalmology (Rochester, Minn.), 2014-01, Vol.121 (1), p.202 [Peer Reviewed Journal]Copyright © 2014 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved. ;EISSN: 1549-4713 ;DOI: 10.1016/j.ophtha.2013.08.012 ;PMID: 24084497Digital Resources/Online E-Resources |
|
10 |
Material Type: Article
|
Efficacy and Safety of Brolucizumab for Diabetic Macular Edema: The KINGFISHER Randomized Clinical TrialJAMA ophthalmology, 2023-12, Vol.141 (12), p.1152 [Peer Reviewed Journal]EISSN: 2168-6173 ;DOI: 10.1001/jamaophthalmol.2023.5248 ;PMID: 37971723Digital Resources/Online E-Resources |
|
11 |
Material Type: Article
|
Early Response to Anti–Vascular Endothelial Growth Factor and Two-Year Outcomes Among Eyes With Diabetic Macular Edema in Protocol TAmerican journal of ophthalmology, 2018-11, Vol.195, p.93-100 [Peer Reviewed Journal]2018 Elsevier Inc. ;Copyright © 2018 Elsevier Inc. All rights reserved. ;COPYRIGHT 2018 Elsevier B.V. ;Copyright Elsevier Limited Nov 2018 ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2018.07.030 ;PMID: 30077569Full text available |
|
12 |
Material Type: Article
|
Anti-Tumor Necrosis Factor α versus Tocilizumab in the Treatment of Refractory Uveitic Macular Edema: A Multicenter Study from the French Uveitis NetworkOphthalmology (Rochester, Minn.), 2022-05, Vol.129 (5), p.520 [Peer Reviewed Journal]Copyright © 2021 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved. ;EISSN: 1549-4713 ;DOI: 10.1016/j.ophtha.2021.11.013 ;PMID: 34793830Digital Resources/Online E-Resources |
|
13 |
Material Type: Article
|
Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDEOphthalmology (Rochester, Minn.), 2012-04, Vol.119 (4), p.789 [Peer Reviewed Journal]Copyright © 2012 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved. ;EISSN: 1549-4713 ;DOI: 10.1016/j.ophtha.2011.12.039 ;PMID: 22330964Digital Resources/Online E-Resources |
|
14 |
Material Type: Article
|
Efficacy and Safety of Suprachoroidal CLS-TA for Macular Edema Secondary to Noninfectious Uveitis: Phase 3 Randomized TrialOphthalmology (Rochester, Minn.), 2020-07, Vol.127 (7), p.948 [Peer Reviewed Journal]Copyright © 2020 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved. ;EISSN: 1549-4713 ;DOI: 10.1016/j.ophtha.2020.01.006 ;PMID: 32173113Digital Resources/Online E-Resources |
|
15 |
Material Type: Article
|
Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema: Extrapolation of Data to Clinical PracticeJAMA ophthalmology, 2016-01, Vol.134 (1), p.95 [Peer Reviewed Journal]EISSN: 2168-6173 ;DOI: 10.1001/jamaophthalmol.2015.4110 ;PMID: 26512939Digital Resources/Online E-Resources |
|
16 |
Material Type: Article
|
Five-Year Outcomes after Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T Extension Study)Ophthalmology (Rochester, Minn.), 2020-09, Vol.127 (9), p.1201 [Peer Reviewed Journal]Copyright © 2020 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved. ;EISSN: 1549-4713 ;DOI: 10.1016/j.ophtha.2020.03.021 ;PMID: 32402554Digital Resources/Online E-Resources |
|
17 |
Material Type: Article
|
The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edemaOphthalmology (Rochester, Minn.), 2011-04, Vol.118 (4), p.615 [Peer Reviewed Journal]Copyright © 2011 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved. ;EISSN: 1549-4713 ;DOI: 10.1016/j.ophtha.2011.01.031 ;PMID: 21459215Digital Resources/Online E-Resources |
|
18 |
Material Type: Article
|
Mechanism and Therapy of Brain Edema after Intracerebral HemorrhageCerebrovascular diseases (Basel, Switzerland), 2016-01, Vol.42 (3-4), p.155-169 [Peer Reviewed Journal]2016 S. Karger AG, Basel ;2016 S. Karger AG, Basel. ;ISSN: 1015-9770 ;EISSN: 1421-9786 ;DOI: 10.1159/000445170 ;PMID: 27110940Digital Resources/Online E-Resources |
|
19 |
Material Type: Article
|
A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2Ophthalmology (Rochester, Minn.), 2010-06, Vol.117 (6), p.1078 [Peer Reviewed Journal]Copyright 2010 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved. ;EISSN: 1549-4713 ;DOI: 10.1016/j.ophtha.2010.03.045 ;PMID: 20416952Digital Resources/Online E-Resources |
|
20 |
Material Type: Article
|
Ranibizumab for edema of the macula in diabetes study: 3-year outcomes and the need for prolonged frequent treatmentJAMA ophthalmology, 2013-02, Vol.131 (2), p.139 [Peer Reviewed Journal]EISSN: 2168-6173 ;DOI: 10.1001/2013.jamaophthalmol.91 ;PMID: 23544200Digital Resources/Online E-Resources |